• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3D生物打印在肿瘤免疫逃逸建模中的应用前景

Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.

作者信息

Staros Rafał, Michalak Agata, Rusinek Kinga, Mucha Krzysztof, Pojda Zygmunt, Zagożdżon Radosław

机构信息

Department of Immunology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-006 Warsaw, Poland.

Department of Regenerative Medicine, Maria Sklodowska-Curie National Institute of Oncology, 02-781 Warsaw, Poland.

出版信息

Cancers (Basel). 2022 Jun 26;14(13):3126. doi: 10.3390/cancers14133126.

DOI:10.3390/cancers14133126
PMID:35804898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9265021/
Abstract

In a living organism, cancer cells function in a specific microenvironment, where they exchange numerous physical and biochemical cues with other cells and the surrounding extracellular matrix (ECM). Immune evasion is a clinically relevant phenomenon, in which cancer cells are able to direct this interchange of signals against the immune effector cells and to generate an immunosuppressive environment favoring their own survival. A proper understanding of this phenomenon is substantial for generating more successful anticancer therapies. However, classical cell culture systems are unable to sufficiently recapture the dynamic nature and complexity of the tumor microenvironment (TME) to be of satisfactory use for comprehensive studies on mechanisms of tumor immune evasion. In turn, 3D-bioprinting is a rapidly evolving manufacture technique, in which it is possible to generate finely detailed structures comprised of multiple cell types and biomaterials serving as ECM-analogues. In this review, we focus on currently used 3D-bioprinting techniques, their applications in the TME research, and potential uses of 3D-bioprinting in modeling of tumor immune evasion and response to immunotherapies.

摘要

在活的生物体中,癌细胞在特定的微环境中发挥作用,在这个微环境里,它们与其他细胞以及周围的细胞外基质(ECM)交换大量的物理和生化信号。免疫逃逸是一种与临床相关的现象,在这种现象中,癌细胞能够针对免疫效应细胞引导这种信号交换,并产生有利于自身存活的免疫抑制环境。正确理解这一现象对于开发更成功的抗癌疗法至关重要。然而,传统的细胞培养系统无法充分重现肿瘤微环境(TME)的动态特性和复杂性,难以令人满意地用于肿瘤免疫逃逸机制的全面研究。反过来,3D生物打印是一种快速发展的制造技术,利用这种技术可以生成由多种细胞类型和充当ECM类似物的生物材料组成的精细结构。在这篇综述中,我们重点关注当前使用的3D生物打印技术、它们在TME研究中的应用,以及3D生物打印在肿瘤免疫逃逸建模和免疫治疗反应方面的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/7bf16a1cae71/cancers-14-03126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/fd278f213270/cancers-14-03126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/6eb6e4c79e3a/cancers-14-03126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/7bf16a1cae71/cancers-14-03126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/fd278f213270/cancers-14-03126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/6eb6e4c79e3a/cancers-14-03126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a4/9265021/7bf16a1cae71/cancers-14-03126-g003.jpg

相似文献

1
Perspectives for 3D-Bioprinting in Modeling of Tumor Immune Evasion.3D生物打印在肿瘤免疫逃逸建模中的应用前景
Cancers (Basel). 2022 Jun 26;14(13):3126. doi: 10.3390/cancers14133126.
2
Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.理解和改进癌症的细胞免疫疗法:从细胞制造到肿瘤免疫模型。
Adv Drug Deliv Rev. 2021 Dec;179:114003. doi: 10.1016/j.addr.2021.114003. Epub 2021 Oct 13.
3
Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.通过 3D 生物打印模拟肿瘤微环境:3D 癌症建模。
Biofabrication. 2022 May 31;14(3). doi: 10.1088/1758-5090/ac6d11.
4
3D Bioprinting for Models of Oral Cancer: Toward Development and Validation.用于口腔癌模型的3D生物打印:迈向开发与验证
Bioprinting. 2021 Jun;22. doi: 10.1016/j.bprint.2021.e00132.
5
3D Bioprinting and Its Application to Military Medicine.3D 生物打印及其在军事医学中的应用。
Mil Med. 2020 Sep 18;185(9-10):e1510-e1519. doi: 10.1093/milmed/usaa121.
6
Can 3D bioprinting solve the mystery of senescence in cancer therapy?3D 生物打印能否解开癌症治疗中衰老的奥秘?
Ageing Res Rev. 2022 Nov;81:101732. doi: 10.1016/j.arr.2022.101732. Epub 2022 Sep 12.
7
Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management.生物墨水:用于抗癌药物发现和癌症管理的 3D 生物打印工具。
Drug Discov Today. 2021 Jul;26(7):1574-1590. doi: 10.1016/j.drudis.2021.03.010. Epub 2021 Mar 16.
8
Bioprinting for cancer research.生物打印在癌症研究中的应用。
Trends Biotechnol. 2015 Sep;33(9):504-13. doi: 10.1016/j.tibtech.2015.06.007. Epub 2015 Jul 24.
9
3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.3D 生物打印的人乳腺来源细胞外基质水凝胶中的乳腺类器官和肿瘤类器官。
Acta Biomater. 2019 Sep 1;95:201-213. doi: 10.1016/j.actbio.2019.06.017. Epub 2019 Jun 21.
10
Reconstruction of tumor microenvironment viathree-dimensional models.重建肿瘤微环境的三维模型。
Biofabrication. 2023 May 24;15(3). doi: 10.1088/1758-5090/acd1b8.

引用本文的文献

1
Does the Organ Matter in PTLD Development in Solid Organ Transplant Recipients? A Multicenter Observational Study of Risk and Prognostic Factors.实体器官移植受者发生移植后淋巴增殖性疾病时器官是否起作用?一项关于风险和预后因素的多中心观察性研究。
Cancers (Basel). 2025 May 25;17(11):1770. doi: 10.3390/cancers17111770.
2
3D-Bioprinted Co-Cultures of Glioblastoma Multiforme and Mesenchymal Stromal Cells Indicate a Role for Perivascular Niche Cells in Shaping Glioma Chemokine Microenvironment.3D 生物打印复发性脑胶质瘤与间充质基质细胞共培养提示血管周龛细胞在塑造脑胶质瘤趋化因子微环境中的作用。
Cells. 2024 Aug 23;13(17):1404. doi: 10.3390/cells13171404.
3

本文引用的文献

1
Bioprinting of 3D tissues/organs combined with microfluidics.3D组织/器官的生物打印与微流体技术相结合。
RSC Adv. 2018 Jun 19;8(39):21712-21727. doi: 10.1039/c8ra03022g. eCollection 2018 Jun 13.
2
Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients.肾移植与肝移植受者移植后淋巴细胞增生性疾病风险及预后因素的比较
Cancers (Basel). 2022 Apr 13;14(8):1953. doi: 10.3390/cancers14081953.
3
Organoid Models for Precision Cancer Immunotherapy.类器官模型在精准癌症免疫治疗中的应用
Bioprinted research models of urological malignancy.
泌尿外科恶性肿瘤的生物打印研究模型
Exploration (Beijing). 2024 Feb 20;4(4):20230126. doi: 10.1002/EXP.20230126. eCollection 2024 Aug.
4
Nanostructured Biomaterials in 3D Tumor Tissue Engineering Scaffolds: Regenerative Medicine and Immunotherapies.三维肿瘤组织工程支架中的纳米结构生物材料:再生医学和免疫疗法。
Int J Mol Sci. 2024 May 16;25(10):5414. doi: 10.3390/ijms25105414.
5
3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.3D 生物打印肿瘤模型:通过重现肿瘤微环境克服免疫治疗耐药性的快速便捷平台。
Cell Oncol (Dordr). 2024 Aug;47(4):1113-1126. doi: 10.1007/s13402-024-00935-9. Epub 2024 Mar 23.
6
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.新型靶向癌胚抗原相关细胞黏附分子(CEACAM)的基于2A3单域抗体的嵌合抗原受体T细胞在体外和体内均产生抗癌作用。
Cancer Immunol Immunother. 2024 Jan 27;73(2):30. doi: 10.1007/s00262-023-03602-4.
7
Three-Dimensional Cell Culture Systems in Pediatric and Adult Brain Tumor Precision Medicine.儿科和成人脑肿瘤精准医学中的三维细胞培养系统
Cancers (Basel). 2022 Dec 2;14(23):5972. doi: 10.3390/cancers14235972.
8
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.免疫逃逸作为癌症免疫治疗的主要挑战
Cancers (Basel). 2022 Jul 26;14(15):3622. doi: 10.3390/cancers14153622.
Front Immunol. 2022 Apr 5;13:770465. doi: 10.3389/fimmu.2022.770465. eCollection 2022.
4
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche.静止期癌细胞通过形成免疫抑制微环境来抵抗 T 细胞攻击。
Cell. 2022 May 12;185(10):1694-1708.e19. doi: 10.1016/j.cell.2022.03.033. Epub 2022 Apr 20.
5
Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma.基于3D生物打印模型的多组学分析创新了骨肉瘤治疗靶点的发现。
Bioact Mater. 2022 Mar 29;18:459-470. doi: 10.1016/j.bioactmat.2022.03.029. eCollection 2022 Dec.
6
Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination.类器官在致癌模型构建和肿瘤疫苗接种中的应用。
Front Oncol. 2022 Mar 17;12:855996. doi: 10.3389/fonc.2022.855996. eCollection 2022.
7
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.由相同初始致癌驱动因素引起的鳞状细胞癌中预先存在的不同免疫谱导致对免疫检查点抑制剂的不同反应。
J Exp Clin Cancer Res. 2022 Apr 2;41(1):123. doi: 10.1186/s13046-022-02337-x.
8
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.患者来源的肿瘤类器官的临床转化——瓶颈与策略
Biomark Res. 2022 Mar 10;10(1):10. doi: 10.1186/s40364-022-00356-6.
9
Recent Advances of Deep Learning for Computational Histopathology: Principles and Applications.深度学习在计算组织病理学中的最新进展:原理与应用
Cancers (Basel). 2022 Feb 25;14(5):1199. doi: 10.3390/cancers14051199.
10
The role of Th17 cells in the pathogenesis and treatment of breast cancer.辅助性T细胞17在乳腺癌发病机制及治疗中的作用
Cancer Cell Int. 2022 Mar 5;22(1):108. doi: 10.1186/s12935-022-02528-8.